Purchase Order W81K0022P0048
- Not listed
- This federal contract award with ID 36C26324D0041|36C26324N0477 is for the delivery of 503B compounding pharmaceuticals to the U.S. Department of Veterans Affairs (VA), specifically supporting the Veterans Integrated Service Network 23, which covers the Houston, Texas area. The contract was awarded to Wells Pharma of Houston LLC, a for-profit limited liability company that specializes in pharmaceutical product manufacturing and distribution for federal healthcare agencies. The contract has a...
- This federal contract award is a firm fixed-price delivery order valued at $12,279.88, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of various pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, and pain management, as well as specialized medical supplies. The contract is funded by the Defense Logistics Agency (DLA),...
- This is a $505,112.46 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is not set aside and represents an open competition. It is a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $875,412.52 and a period of performance through June 5, 2023. The award is not set aside for any specific business type, indicating open competition. The contract requires Amerisourcebergen Drug Corp to provide a wide range of pharmaceutical products and medical supplies,...
- This is a $800,188.67 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is not set aside for any specific business type, indicating open competition. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., which provides a comprehensive global pharmaceutical support vehicle for the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $945,242.69 contract is for the delivery of a variety of pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, antibiotics, and specialized medical supplies....
- This is a $720,005.53 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including prescription medications, medical devices, specialty pharmaceuticals, vaccines, syringes, and other healthcare-related items, to support military healthcare programs worldwide. The...
- This federal contract award, valued at $928,301.94, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a comprehensive global pharmaceutical support vehicle for the Defense Health...
- This federal contract award, valued at $695,515.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the provision of various pharmaceutical products and medical supplies to support military healthcare programs. The contract is not set aside and allows for the delivery of a wide range of medications across multiple therapeutic categories, including diabetes treatments, neurological...
- This is a $119,855.00 firm fixed price delivery order federal contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of a variety of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The award is not...
This is a $639,602.69 firm fixed-price purchase order awarded by the Defense Health Agency to Wells Pharma of Houston LLC, a for-profit limited liability company, to provide critical pharmaceutical products including norepinephrine, ketamine, and naloxone solutions. The contract has a performance period through September 30, 2025. This award is related to a previous sources sought notice issued by the Regional Health Contracting Office - Central on behalf of the San Antonio Military Medical Center, which sought to procure similar compounded pharmaceuticals to support medical treatment and healthcare operations. While that opportunity was initially set aside for small businesses, this contract was awarded on an unrestricted basis, indicating Wells Pharma's competitive positioning as a capable supplier of specialized pharmaceutical products to federal healthcare agencies. The company has previously held contracts with the Department of Veterans Affairs and the Defense Health Agency for 503B compounded pharmaceuticals and prefilled syringes.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Naloxone and compounded pharmaceuticals | W81K0022Q0012 | Department of the Army Medical Command | Pre-Solicitation 1/2 | 12/6/21, 4:20 PM | |
Naloxone and compounded pharmaceuticals | W81K0022Q0012 | Department of the Army Medical Command | Special Notice 2/2 | 12/15/21, 1:30 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00012 | Terminate for Convenience | ($268k) | 3/27/25 | |
| P00011 | Funding Only Action | $283.4k | 11/18/24 | |
| P00010 | Funding Only Action | ($111k) | 9/5/24 | |
| P00009 | Funding Only Action | ($11) | 6/24/24 | |
| P00008 | Exercise an Option | $0 | 6/18/24 |